Citius Pharmaceuticals
CTXR
CTXR
73 hedge funds and large institutions have $24.2M invested in Citius Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 22
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$241K | |
| 2 | +$149K | |
| 3 | +$135K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$67.5K |
Top Sellers
| 1 | -$266K | |
| 2 | -$116K | |
| 3 | -$115K | |
| 4 |
Barclays
London,
United Kingdom
|
-$66.9K |
| 5 |
VF
Virtu Financial
New York
|
-$39K |